Cardlytics, Inc. - Common Stock, par value $0.0001 (CDLX)

181 filings reported holding CDLX - Cardlytics, Inc. - Common Stock, par value $0.0001 as of Q2 2024.
Cardlytics, Inc. - Common Stock, par value $0.0001 (CDLX) has 126 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 33.7M shares of 53M outstanding shares and own 63.53% of the company stock.
Largest 10 shareholders include CAS Investment Partners, LLC (6.46M shares), BlackRock Inc. (3.15M shares), VANGUARD GROUP INC (2.41M shares), MORGAN STANLEY (2.17M shares), 683 Capital Management, LLC (2.1M shares), KPS Global Asset Management UK Ltd (1.22M shares), WORLDLY PARTNERS MANAGEMENT, LLC (1.16M shares), BRIGHTLIGHT CAPITAL MANAGEMENT LP (1.07M shares), GEODE CAPITAL MANAGEMENT, LLC (980K shares), and STATE STREET CORP (891K shares).
This table shows the top 126 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.